Overview and Scope
Veterinary point-of-care diagnostics are used for real-time animal health diagnostics, providing clinically meaningful information in clinical practice without relying on clinical laboratory results. It reduces the turnaround time (TAT) of animal test results for clinicians and patients in the prescribed treatment course.
Sizing and Forecast
The veterinary point of care diagnostics market size has grown rapidly in recent years. It will grow from $1.58 billion in 2023 to $1.8 billion in 2024 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to education and awareness programs, integration with telemedicine, focus on infectious disease control, regulatory support and approvals, livestock and production animal management.
The veterinary point of care diagnostics market size is expected to see rapid growth in the next few years. It will grow to $2.97 billion in 2028 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing pet population, preventive healthcare emphasis, remote and rural access needs, personalized veterinary medicine,global health preparedness.. Major trends in the forecast period include technological advancements, product innovations, consumer preference for home testing..
To access more details regarding this report, visit the link:
Segmentation & Regional Insights
The veterinary point of care diagnostics market covered in this report is segmented –
1) By Product : Consumables, Reagents, and Kits, Instruments and Devices
2) By Animal Type: Companion Animals, Livestock Animals
3) By Disease: Infectious Diseases, Metabolic Diseases, Other Diseases
4) By Technology: Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, Urinalysis, Other Technologies
5) By End User: Veterinary Clinics, Veterinary Hospitals and Academic Institutes, Home Care Settings
North America was the largest region in the veterinary point of care diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary point of care diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8238&type=smp
Major Driver Impacting Market Growth
The increasing companion animal population is expected to propel the veterinary point-of-care diagnostics market growth going forward. Companion animals are pets who share the residential area with humans. An increase in the companion animal population is increasing the demand for veterinary point-of-care diagnostics that enables faster clinical decision-making in the diagnostic, treatment selection and monitoring, and prognosis processes, as well as operational decision-making and resource utilization. For instance, according to the American Pet Products Association, a US-based not-for-profit industry association’s 2021-2022 National Pet Owners Survey, 70% of all US households have a companion animal. Therefore, the increasing companion animal population contributes to the veterinary point-of-care diagnostics market growth.
Key Industry Players
Major companies operating in the veterinary point of care diagnostics market report are Zoetis Inc., IDEXX Laboratories Inc., Heska Corporation, Virbac Animal Health India Pvt Ltd, Samsung Neurologica Corporation, Eurolyser Diagnostica GmbH, Randox Laboratories Ltd, Anipoc Ltd, Carestream Health Inc, Fujifilm Sonosite Inc, Neogen Corporation, Mindray Medical International Limited, GE HealthCare Technologies Inc., Abaxis Inc., Agfa-Gevaert N.V., Alvedia, Bio-Rad Laboratories Inc., bioMérieux SA, Bionote Inc., Chembio Diagnostic Systems Inc., Clindiag Systems Co. Ltd., Coris BioConcept, Creative Diagnostics, DiaSys Diagnostic Systems GmbH, Eiken Chemical Co. Ltd., Eurofins Technologies, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Hangzhou AllTest Biotech Co. Ltd., Hologic Inc., InBios International Inc.
The veterinary point of care diagnostics market report table of contents includes:
- Executive Summary
- Market Characteristics
- Market Trends And Strategies
- Impact Of COVID-19
- Market Size And Growth
- Segmentation
- Regional And Country Analysis
…………….
- Competitive Landscape And Company Profiles
- Key Mergers And Acquisitions
- Future Outlook and Potential Analysis
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
